OUR SERVICES

Regulatory Affairs, Drug Development, Pharmacovigilance, Medical Writing, Pricing & Reimbursement, Market Access

MORE

ABOUT US

Partner of many pharmaceutical companies, managing hundreds of multi-task projects, on a worldwide-scale

MORE

EVENTS

Discover next events

MORE
Jun
06
THE 58th AFI SYMPOSIUM
MORE
Jun
06
2018

BLOG

ALL POSTS
May, 11 2018

Elemental Impurities: risk-based control s...

The guideline ICH Q3D - GUIDELINE FOR ELEMENTAL IMPURITIES, which is now fully into force (effective for new marketing authorizati...

READ
May, 07 2018

MEDICAL DEVICES – EUROPEAN REGULATIO...

The European regulation 2017/745 of medical devices will become effective in May 2020 and manufactures, authorized representatives...

READ
Nov, 21 2017

NEW LEGISLATION ABOUT COMPASSIONATE USE IN...

The new legislation about “Discipline of the therapeutic use of an investigational medicinal product” (Ministerial Decree Sept...

READ
RPN @regulatorypharmanet - JUN 4

CONTACT US

Our experts are available to help you with any question you might have








  
I accept THE PRIVACY POLICY